Phase 2 Leukaemia Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are older than 2 years of age
• People whose cancer cells have been tested and show specific markers (called CD33, CD38, CD56, CD123, MucI, and CLL1) detected through laboratory testing of tissue or blood samples
• People who are in reasonably good general health as measured by a standard health scoring system, with a life expectancy of more than 2 months (confirm with trial site)
• People whose heart, liver, and kidneys are functioning well enough to meet specific laboratory test thresholds set by the trial
• People whose haemoglobin (a measure of red blood cells) is at or above a certain level as set by the trial
• People who have no medical reasons that would prevent a cell collection procedure
• People who are able to understand the study and are willing to sign a written consent form

Who may not be able to join:

• People with a serious illness or medical condition that would make it unsafe to follow the trial's treatment plan, including any active infection that is not under control
• People with an active bacterial, fungal, or viral infection that has not been adequately treated
• People who are known to have HIV or Hepatitis B virus
• People who are pregnant or currently breastfeeding
• People who have used steroid medications (glucocorticoids) for a whole-body (systemic) treatment within the week before entering the trial
• People who have previously received any gene therapy treatment
• People whom the trial investigators judge may not be suitable or may not be able to follow the study requirements

Important: Always verify eligibility with the trial site directly before applying.